MYCO:CC News and Press, MYDECINE INNOVATIONS GROUP INC. From 03/17/22

New research on addiction conducted by scientists from the University of California-Irvine has discovered links between metabolism and the circadian rhythm. The circadian clock relies on various interactions between systems to maintain regular timing and is entwined with... Read more ...

Last week, a Missouri legislator filed a measure that would legalize an extensive range of psychedelic drugs for therapeutic use and decriminalize low-level possession in the state. The measure was sponsored by Republican lawmaker, Rep. Tony Lovasco. It is the latest example of psychedelic...

The numbers of individuals succumbing to drug overdoses has increased significantly these last few years, which has left many communities and families devastated. Figures show that between September 2020 and September 2021, more than 104,000 individuals in America died due to drug overdoses...

Mydecine recently reported a positive Pre-IND meeting with the FDA for the MYCO-001 smoking cessation study According to the Center for Disease Control (“CDC”), tobacco is the leading cause of preventable deaths in the U.S. Following the FDA meeting, the company now inte...

Mydecine Innovations (NEO: MYCO) (OTC: MYCOF) is a biotechnology and digital technology company aiming to transform the treatment of mental health and addiction disorders. The company recently made two announcements that show a more immediate response to providing mental health soluti...

Psychedelics were made illegal when the Controlled Substances Act of 1970 was enacted, with most of the substances  being classified as Schedule I . Substances under this category are considered to have a high potential for abuse with no current accepted medical use. However, recent ...

Mydecine Innovations (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) is a biotechnology company developing innovative first-and-second-generation novel therapeutics for the treatment of mental health and addiction using world-class technology and drug development infrastructure. Mydecine was founded ...

A new study has found that family members of individuals who have been hospitalized in the ICU due to coronavirus infections may suffer from PTSD in comparison with family members of patients with acute respiratory distress syndrome caused by other ailments. The study, which was conducted ...

Last week, legislators in the state of Utah sent a measure to the governor that would establish a task force to conduct research on the therapeutic potential of various psychedelic substances and make recommendations on potential regulations for their legal use. The bill, which was introdu...

Mydecine Innovations (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) , a biotechnology company aiming to transform the treatment of mental health and addiction disorders, today announced that it will be attending three investor conferences in March. The upcoming events include the 34th Annual Ro...